Santen Pharmaceutical Co (TSE:4536) Other Operating Expense : 円23,224 Mil (TTM As of Mar. 2024)

View and export this data going back to 1964. Start your Free Trial

What is Santen Pharmaceutical Co Other Operating Expense?

Santen Pharmaceutical Co's Other Operating Expense for the three months ended in Mar. 2024 was 円11,106 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was 円23,224 Mil.

Santen Pharmaceutical Co's quarterly Other Operating Expense increased from Sep. 2023 (円3,369 Mil) to Dec. 2023 (円6,501 Mil) and increased from Dec. 2023 (円6,501 Mil) to Mar. 2024 (円11,106 Mil).

Santen Pharmaceutical Co's annual Other Operating Expense increased from Mar. 2022 (円9,824 Mil) to Mar. 2023 (円44,623 Mil) but then declined from Mar. 2023 (円44,623 Mil) to Mar. 2024 (円23,224 Mil).

Santen Pharmaceutical Co Other Operating Expense Historical Data

The historical data trend for Santen Pharmaceutical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santen Pharmaceutical Co Other Operating Expense Chart

Santen Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Operating Expense

Get a 7-Day Free Trial

16,488.00

35,532.00

9,824.00

44,623.00

23,224.00

Santen Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															7,323.00	2,248.00	3,369.00	6,501.00	11,106.00

Santen Pharmaceutical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円23,224 Mil.

Santen Pharmaceutical Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Santen Pharmaceutical Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Santen Pharmaceutical Co (TSE:4536) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Santen Pharmaceutical Co Ltd (TSE:4536) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

SNPHY:USA SNPHF:USA SZD:Germany

Address

Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka, JPN, 530-8552

Website

http://www.santen.co.jp

Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.

Santen Pharmaceutical Co (TSE:4536) Headlines

No Headlines